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Immunity to intestinal helminth infections has
been well studied, but the mechanism of helminth
killing prior to expulsion remains unclear. Here
we identify epithelial-cell-derived phospholipase A2
group 1B (PLA2g1B) as a host-derived endogenous
anthelmintic. PLA2g1B is elevated in resistant mice
and is responsible for killing tissue-embedded larvae.
Despite comparable activities of other essential type-
2-dependent immune mechanisms, Pla2g1b/ mice
failed to expel the intestinal helminths Heligmoso-
moides polygyrus or Nippostrongylus brasiliensis.
Expression of Pla2g1b by epithelial cells was depen-
dent upon intestinal microbiota, adaptive immunity,
and common-gamma chain-dependent signaling.
Notably, Pla2g1b was downregulated in susceptible
mice and inhibited by IL-4R-signaling in vitro, uncou-
pling parasite killing from expulsion mechanisms.
Resistance was restored in Pla2g1b/mice by treat-
ing infective H. polygyrus L3 larvae with PLA2g1B,
which reduced larval phospholipid abundance. These
findings uncover epithelial-cell-derivedPla2g1b as an
essential mediator of helminth killing, highlighting a
previously overlooked mechanism of anti-helminth
immunity.
INTRODUCTION
Intestinal helminth infections are highly prevalent in developing
countries, with chronic infections causing significant host mor-
bidity (Hotez et al., 2008). With the emergence of drug-resistant
helminths, a limited number of effective anthelmintics, and stall-
ing vaccine efforts, new therapeutic avenues require a better484 Cell Host & Microbe 22, 484–493, October 11, 2017 ª 2017 The
This is an open access article under the CC BY license (http://creativeunderstanding of anti-helminth immunity and killing. Expulsion
mechanisms of intestinal helminths have been widely studied
and reported; however, the mechanism of helminth killing in
the tissue prior to expulsion remain unclear. Upon infection, acti-
vated epithelial cells secrete a suite of alarmins, including inter-
leukin (IL)-25, thymic stromal lymphopoietin (TSLP), and IL-33,
which promote activation and differentiation of innate and adap-
tive immune cells, leading to type 2 inflammation (Anthony et al.,
2006; Katona et al., 1991; McCoy et al., 2008; Urban et al.,
1991a). IL-4-driven CD4+ T helper (Th)-2 cell differentiation, in
combination with group 2 innate lymphoid cell (ILC2) activation,
leads to the secretion of a suite of cytokines including IL-4,
IL-5, IL-9, and IL-13, which propagate type 2 inflammation and
activate the local stroma (Grencis et al., 1991; Hashimoto
et al., 2009). The resulting reorganization of intestinal tissue—
with goblet cell hyperplasia, mucus hyper-secretion, and
smooth muscle contraction (Gerbe et al., 2016; Hashimoto
et al., 2009; Hasnain et al., 2010, 2011; Howitt et al., 2016; Mur-
akami et al., 2016)—alongside type 2 cytokine-driven immuno-
logical changes such as B cell class switching (McCoy et al.,
2008) and alternate activation of macrophages (Anthony et al.,
2006) contributes to parasite expulsion. However, the precise
mechanism of parasite damage and killing, whether in tissue or
lumen, has remained unclear.RESULTS AND DISCUSSION
To identify local tissue responses and novel mechanisms of
intestinal helminth killing during anti-helminth immunity, we
used the natural mouse intestinal helminth H. polygyrus (H.p.).
Following oral infection, stage 3 larvae (L3) migrate to the
duodenum and proximal jejunum, where they penetrate the
mucosae and embed into the muscularis externa, undergoing
developmental moults before emerging into the lumen as adult
worms (Camberis et al., 2003; Valanparambil et al., 2014).
C57BL/6 mice are naturally susceptible to a primary (1) H.p.
infection, establishing a chronic infection (Reynolds et al.,Authors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. Pla2g1b and Lipid Metabolism
Correlate with Resistance to Intestinal Hel-
minth Infection
(A) C57BL/6 mice were orally infected with 200 L3
H. polygyrus (H.p.) larvae on day 0. A cohort of
mice were sacrificed 7 days after 1 H.p. infection
(H.p. 1). Remaining mice were drug treated (Rx)
on days 14 and 15. Mice were then reinfected with
H.p. on day 35 or day 56 and harvested 7 days after
infection (H.p. 2).
(B) H&E staining of the small intestine from H.p. 1
and H.p. 2 (D42).
(C) Ratio-of-ratios analysis of differentially ex-
pressed genes in H.p. 1 and H.p. 2 (D42) identi-
fied distinct gene clusters (C1-3).
(D) Top 10 pathways predicted to be activated
more highly in and H.p. 2 than H.p. 1 (both rela-
tive to naive, 2-fold filter, p < 0.05).
(E) Lipid metabolism pathway predicted activation
score (relative to naive, 2-fold filter, p < 0.05).
(F) Pla2g1b expression in small intestine from RNA
sequencing data, confirmed by qPCR.
Data are represented asmean ± SEM; n = 8, * = p <
0.05, ** = p < 0.01 determined using a one-way
ANOVA with Dunnett’s multiple comparison anal-
ysis. See also Figure S1 and Tables S1–S3.2012). Following drug cure of a 1 infection (Rx), C57BL/6 mice
are resistant to a secondary (2) H.p. challenge infection (Finkel-
man et al., 1997; model, Figure 1A). Resistance to H.p. 2 infec-
tion correlated with substantial inflammation and tissue remod-
eling (Figure 1B), and significantly more transcriptional activity
in duodenal tissue than in 1 infection (H.p. 1), with 665 genes
differentially expressed in 2 infection compared to 145 genes
in 1 infection and 116 common genes (relative to naive, 2-fold
filter, p < 0.05) (Figure S1A). Using a ratio-of-ratios analysis to
specifically identify genes expressed in resistant mice (H.p. 2),
we identified three transcriptional clusters based on their
expression relative to uninfectedmice and relative to susceptible
mice (H.p. 1) (Figure 1C, C1-C3; Tables S1–S3). Cluster 1 (C1)
identified common and quantitative differences between 1
and 2 infection, including several genes previously described
in immunity to H.p. (Anthony et al., 2006; Herbert et al., 2009).
Cluster 2 (C2) identified qualitative differences between suscep-
tible and resistant mice highlighting genes upregulated inH.p. 2
infection only. Many of these genes have not previouslyCell Host & Mbeen described in immunity to H.p.
Cluster 3 (C3) identified qualitative differ-
ences downregulated in H.p. 2 infection
only. Pathway analysis reflected quantita-
tive and qualitative transcriptional differ-
ences with a greater increase in im-
mune-activated pathways in resistant
mice, as previously described (Allen and
Maizels, 2011; Anthony et al., 2007; Mai-
zels et al., 2012), in addition to an increase
in lipid metabolism pathways in H.p. 2
that was not previously described during
anti-helminth immunity (Figures 1D and
S1B). Increased activation of lipid meta-bolism pathways was also evident in resistant mice with or
without a 2 challenge infection and was maintained for up to
48 days after drug treatment (Figure 1E), correlating with long-
term resistance to reinfection following drug treatment (Urban
et al., 1991b). Within C2 genes, which were upregulated in H.p.
2 infection only, we identified group 1B phospholipase A2,
Pla2g1b, a member of a large family of secreted (sPLA2) en-
zymes that regulate lipid metabolism through hydrolysis of phos-
pholipids (Labonte´ et al., 2006, 2010). Pla2g1b was significantly
increased in drug-treated mice with or without challenge infec-
tion, correlating with lipid metabolism pathways and resistance
to H.p. (Figure 1F). The enzymatic activity of PLA2 in the small in-
testine wasmarginally increased in susceptiblemice but dramat-
ically increased in resistant mice (Figure S1C), reflecting a broad
increase in several PLA2 enzymes in resistant mice (Figure S1D).
To formally testwhether elevatedPLA2g1Bcontributed to resis-
tance to intestinal helminth infections, we infected Pla2g1b/
mice with a variety of small- or large-intestinal helminths.
Strikingly, Pla2g1b was essential for resistance to H.p., withicrobe 22, 484–493, October 11, 2017 485
Figure 2. Type 2 Immunity Is Insufficient for Resistance to Intestinal Helminth Infection in the Absence of Pla2g1b
(A) Luminal H.p. worms in the small intestine 14 days after 2 infection.
(B) Fecal egg counts 14 days after 2 H.p. infection.
(C) Frequency of Il4gfp+CD44hi CD4+ cells in the mesenteric lymph node (mLN) and the spleen of mice 7 days after 2 infection.
(D) Frequency of cytokine+ CD4+CD44hi cells in the mLN of mice 7 days after 2 infection.
(E) ex vivo H.p. antigen-specific cytokine production from the mLN of mice 7 days after 2 infection.
(F) Gene expression in the small intestine of mice 7 days after 2 H.p. infection.
(G) H.p. antigen-specific IgG1 in the serum from mice 7 days after 2 H.p. infection.
(H) Mucus staining (Alcian blue-periodic acid-Schiff) of the small intestine from mice 7 days after 2 H.p. infection.
(I) RNA-sequencing-generated transcriptional landscape of the small intestine of WT and Pla2g1b/ mice 7 days after 2 H.p. infection.
(J) Top 10 pathways predicted to be activated 7 days after 2 H.p. infection (relative to strain-naive, 2-fold filter, p < 0.05).
(K) Lipid metabolism pathway predicted activation score 7 days after 2 H.p. infection (relative to strain-naive, 2-fold filter, p < 0.05).
Data are represented as mean ± SEM, n = 5–6, representative of at least three independent experiments; ns = not significant, * = p < 0.05, **** = p < 0.0001
determined using a two-way ANOVA with Sidak’s multiple comparison analysis or an unpaired two-tailed t test. See also Figures S2–S4.Pla2g1b/mice failing to expel a 2 H.p. infection and retaining a
patent infection (Figures 2A and 2B). The absence of PLA2g1B did
not affect theexpressionofotherdetectablePLA2 familymembers
(Figure S1E). PLA2g1b was also required for expulsion of
N. brasiliensis, which also infects the small intestine (Figure S2A);
however, Pla2g1b was not required for expulsion of the cecum-
dwelling whipworm Trichuris muris (Figure S2B).
IL-4 and type 2 immune responses orchestrate many of the
known anti-helminth, immune-driven expulsion pathways (Hashi-
moto et al., 2009). We therefore assessed innate and adaptive
type 2 immune responses in Pla2g1b/ mice and, to our sur-
prise, found that all measured type 2 immune responses were486 Cell Host & Microbe 22, 484–493, October 11, 2017intact. Specifically, by crossing Pla2g1b/mice onto an Il4gfp re-
porter background or by measuring IL-4 protein by intra-cellular
staining, we found that Th2 cell commitment and differentiation
were equivalent between genotypes (Figures 2C and 2D). Para-
site-specific, Th2-derived cytokines IL-5 and IL-13 were also
comparable (Figure 2E), with no measurable difference in IFNg+
or IL-17A+ T cells (Figure 2D). Lymphocyte populations in
Pla2g1b/mice, both at baseline and following 2 H.p. infection,
were comparable to WT mice, including both CD4+ and CD8+
T cells, ILC2s, which support early Th2 differentiation (Pelly
et al., 2016) and regulatory T cells, which inhibit type 2 immune
responses (Wilson et al., 2005; Figures S2C–S2J and S3A).
Figure 3. Intestinal Pla2g1b Is Regulated by
the Microbiota and Rag- and Common
Gamma Chain-Dependent Cells in Resistant
Mice
(A) Kinetics of Pla2g1b expression in the small in-
testine during H.p. 2 infection model.
(B) Kinetics of Pla2g1b expression in the small in-
testine during H.p. 1 infection, n = 6.
(C) Pla2g1b expression at day 28 (14 days post-Rx)
in the small intestine, n = 5.
(D) Pla2g1b expression at day 28 (14 days post-Rx,
1-Rx) in the small intestine following anti-IL-4
(aIL-4) or Isotype (Iso) treatment, n = 9–10 (data
pooled from two independent experiments).
(E) Pla2g1b expression at day 28 (14 days post-Rx,
1 Rx) in the small intestine, n = 7–10 (data pooled
from two independent experiments).
(F) Pla2g1b expression at day 28 (14 days post-Rx,
1 Rx) in the small intestine following antibiotic
treatment, n = 9–10 (data pooled from two inde-
pendent experiments).
Data are represented asmean ± SEM, n = 3. All data
are representative of at least two independent ex-
periments; * = p < 0.05, ** = p < 0.01, determined
using a one-way ANOVA with Dunnett’s multiple
comparison analysis, unpaired t test, or a Mann-
Whitney test.Alternatively activated macrophage-associated genes, which are
also essential for immunity to H.p. (Anthony et al., 2006), were
similar between genotypes in vivo (Figure 2F) and following polar-
ization in vitro (Figure S3B). Finally, B cell frequencies and serum
antibodies, includingH.p.-specific IgG1and IgE,which are impor-
tant for preventing adult worm development (McCoy et al., 2008),
were comparable betweenWT and Pla2g1b/mice (Figures 2G,
S3C, and S3D). Physiological responses—including goblet cell
hyperplasia and mucus hypersecretion, which correlate with
expulsion—were also comparable between WT and Pla2g1b/
mice (Figures 2H and S3E). RNA sequencing and pathway anal-
ysis of the transcriptome of duodenal tissue from naive and in-
fected Pla2g1b/ mice 7 days after 2 H.p. infection identified
that the transcriptional responses and associated pathways
were very similar to WT mice with the exception of 2 genes,
Pla2g1b and Lars2 (Figures 2I, 2J, and S3F). To our surprise, pre-
dicted activation of lipid metabolism pathways and synthesis of
bioactive lipids, including cysteine leukotrienes and prostaglandin
E 2 (PGE2), serum fatty acid metabolites, and serum Lysophos-
phatidylcholines (LPC), were unaffected in Pla2g1b/mice (Fig-
ures 2K and S3G–S3I), most likely due to unaltered expression of
other phospholipase A2 enzymes (Figure S1E). These data sug-
gest that the failure to expel H.p. in Pla2g1b/ mice was not
due to altered lipid metabolism or known immune-mediated or
stromal-associated expulsion mechanisms.
To determine the source of PLA2g1B and its regulation, we
monitored Pla2g1b expression in duodenal tissue following 1
infection, 1 infection and drug cure, and 2 infection. Pla2g1b
was significantly upregulated 14 days after drug cure of a 1
infection (day 28) and was maintained with or without a 2
infection (Figures 3A and 1F). This correlated with the develop-
ment and maintenance of resistance to 2 infection. Despite astrong type 2 immune response, Pla2g1b expression was
not upregulated in mice given a 1 infection (Figure 3B) or
following drug treatment alone (Figure 3C), but had a trend
to be reduced. We hypothesize that a 1 H.p. infection may
actively inhibit PLA2g1B through secretion of immunomodula-
tory proteins. However, this remains to be tested. IL-4 is
essential for resistance to a 2 H.p. infection (Urban et al.,
1991b). We therefore investigated whether IL-4 was required
for upregulation of Pla2g1b in resistant mice. Anti-IL-4 anti-
body treatment prior to and during drug-treatment did not pre-
vent Pla2g1b upregulation in resistant mice (Figure 3D), sug-
gesting that Pla2g1b is not regulated in an IL-4 or type-2
immune dependent manner. To test whether Rag-dependent,
adaptive immune cells and common gamma chain (cg)-depen-
dent innate immune cells and signaling were required for
Pla2g1b expression, we infected and drug-treated WT and
Rag2/cg/ mice. Following drug treatment, WT, but not
Rag2/cg/, mice upregulated Pla2g1b, indicating that at
this time prior to immune-mediated active expulsion, adaptive
and cg-dependent signaling was required for the upregulation
of Pla2g1b in vivo (Figure 3E).
To identify additional type 2 independent mechanisms of
Pla2g1b upregulation, we tested whether the host microbiota
contributed to Pla2g1b regulation. Antibiotic-treated mice com-
pletely failed to upregulatePla2g1b (Figure 3F), indicating that in-
testinal microbiota are essential for elevated Pla2g1b expres-
sion. Intestinal microbiota changes following helminth infection
(Giacomin et al., 2016; Rausch et al., 2013; Reynolds et al.,
2014; Zaiss et al., 2015) have previously been reported. How-
ever, whether a microbiota-driven Pla2g1b axis has evolved to
restore intestinal homeostasis and protect from small-intestine
dwelling helminths is unclear.Cell Host & Microbe 22, 484–493, October 11, 2017 487
Figure 4. Epithelial-Cell-Derived Pla2g1b Is Negatively Regulated by IL-4Ra-Signaling
(A) Pla2g1b detection by RNAScope ISH in the small intestine 7 days after 2 H.p. infection.
(B) Pla2g1b expression in fluorescence-activated, cell sorted (FACS) CD45–EpCam+ and CD45+EpCam cells from the intestinal epithelium from naive and
resistant (day 28) mice, n = 6.
(C) Pla2g1b, Retnlb, and Gob5 expression in intestinal organoid cultures following stimulation with rIL-4 and rIL-13.
Data are represented as mean ± SEM, n = 3. All data are representative of at least two independent experiments. * = p < 0.05, ** = p < 0.01, **** = p < 0.0001
determined using an unpaired t test or a Mann-Whitney test. See also Figure S5.In situ hybridization localized Pla2g1b expression to the
epithelial layer following H.p. 2 infection (Figures 4A and S4A)
rather than in the granuloma where larvae embed (Figure S4B).
We confirmed that Pla2g1b was elevated in FACS-purified
CD45–EpCam+ epithelial cells rather than CD45+EpCam– cells
isolated from drug-cured mice compared to naive (Figure 4B).
With the recent identification of tuft cells as important in anti-hel-
minth immunity (Gerbe et al., 2016; Howitt et al., 2016; von
Moltke et al., 2016), we analyzed the expression of tuft-cell-spe-
cific markers in our RNA sequencing data from the H.p. chal-
lenge infection model (Figure 1A). We identified significant upre-
gulation of the tuft cell markers Dclk, Trpm5, Siglec5 and Pou2f3
in resistant H.p. 2 infected, but not in H.p. 1 infected mice (Fig-
ure S4C). Importantly, expression of tuft cell markers, which
peaked transiently following infection, did not correlate with
Pla2g1b expression, which was upregulated following drug488 Cell Host & Microbe 22, 484–493, October 11, 2017cure of 1 infection and maintained with or without 2 challenge
infection. These data suggest that Pla2g1b expression was not
restricted to tuft cells, or at least tuft-cell-associated gene
expression. In addition, although Pla2g1b is abundantly ex-
pressed in the pancreas (Eerola et al., 2006), it was not differen-
tially expressed in the pancreas following infection, drug treat-
ment, or reinfection (Figure S4D). Both our findings (Figures 2
and S3) and previous data (Hollie and Hui, 2011; Labonte´
et al., 2010) suggest that PLA2g1B does not contribute to altered
dietary phospholipid digestion at steady state or during H.p.
infection. To determine how Pla2g1b was regulated in epithelial
cells, we generated ex vivo organoid cultures (Sato et al., 2009)
and found that IL-4R signaling decreased Pla2g1b expression
but increased the expulsion-related genes Relmb (Retnlb) and
Gob5 (Hashimoto et al., 2009; Herbert et al., 2009; Figure 4C).
These data again uncouple Pla2g1b expression from type 2
Figure 5. PLA2g1B Has Direct Anthelmintic
Properties
(A) ATP concentration of H.p. L3 larvae after 24 hr
treatment with PLA2g1B, n = 3.
(B) Number of H.p. larvae imbedded in the small
intestinal wall 5 days after infection following 24 hr
treatment with PLA2g1B, n = 5.
(C) Luminal H.p. worms in the small intestine
14 days after 1 infection following 24 hr treatment
with PLA2g1B, n = 10 (data pooled from two in-
dependent experiments).
(D) Pla2g1b/ or WT mice were orally infected
with 200 L3 H.p. larvae on day 0 and were drug
treated (Rx) on days 14 and 15. Mice were then
reinfected with PLA2g1B-treated L3 H.p. larvae on
day 35 and harvested 14 days after infection (2).
Another cohort of Pla2g1b/ or WT mice were
orally infected with 200 L3 H.p. larvae on day 35
and harvested 14 days after infection (1).
(E) Luminal H.p. worms in the small intestine
14 days after 1 or 2 infection following 24 hr
treatment with PLA2g1B.
(F) Luminal H.p. worms in the small intestine
14 days after 1 infection following 24 hr treatment
with PLA2g1B.
(G) Luminal H.p. worms in the small intestine
14 days after 2 infection following 24 hr treatment
with PLA2g1B.
Data are represented as mean ± SEM, n = 4–5. All
data re representative of at least two independent
experiments. * = p < 0.05, *** = p < 0.001, **** = p <
0.0001 determined using a two-way ANOVA with
Sidak’s multiple comparison analysis, one-way
ANOVA with Dunnett’s multiple comparison anal-
ysis, or an unpaired two-tailed t test. See also
Figure S6.immune pathways that drive expulsion mechanisms (Anthony
et al., 2006; Herbert et al., 2009; Urban et al., 1991b) and suggest
that type 2 immunity may negatively regulate Pla2g1b expres-
sion to protect host tissues from the potent effects of phospho-
lipase enzymes (Murakami et al., 2011).
Other sPLA2 family members can degrade bacterial mem-
branes and protect from fungal infections (Balestrieri et al.,
2009; Degousee et al., 2002; Koduri et al., 2002; Weinrauch
et al., 1998). We therefore asked whether PLA2g1B had a direct
effect on H.p. by treating sheathed or exsheathed L3 H.p. larvae
(to recapitulate the status of the larvae in the small intestine after
passing through the stomach) (Sommerville and Bailey, 1973)
and adult H.p. worms with recombinant PLA2g1B. No effect
was identified on the fitness of treated L3 larvae, isolated L4
larvae, or adult worms, as determined by ATP concentration
(Figures 5A, S5A, and S5B). To test the infectivity and viabilityCell Host & Mof PLA2g1B-treated L3 larvae, we infected
mice with PLA2g1B-treated L3 larvae and
found that PLA2g1B-treated L3 larvae
could embed into the intestinal wall (Fig-
ure 5B) However, significantly fewer
treated larvae developed into adulthood
(Figure 5C), impacting egg recovery in
the feces, although failing to reach statis-
tical significance (Figure S5C). PLA2g1B-mediated effects on L3 larvae were dependent on the catalytic
activity of PLA2g1B as the PLA2 irreversible inhibitor manoalide
completely abrogated the protective effect of PLA2g1B treat-
ment in vitro (Figure S5D).
The protective effect of PLA2g1B-treated L3 larvae during a
1 infection did not recapitulate the full killing, expulsion, and
clearance of worms observed during 2 H.p. infection (Figure 2).
We therefore hypothesized that, for clearance of H.p., a com-
bined PLA2g1B-mediated impact on larvae in concert with
immune-mediated physiological responses would be required.
To test this, we infected and drug cured WT and Pla2g1b/
mice to elicit robust type 2 immune responses (Figure 2) and
challenged mice with vehicle- or PLA2g1B-treated L3 larvae
(model, Figure 5D).WTmice cleared themajority of either vehicle
or PLA2g1B-treated H.p. larvae. Pla2g1b
/ mice failed to
clear vehicle-treated L3 larvae, as expected (Figure 2). However,icrobe 22, 484–493, October 11, 2017 489
Figure 6. Pla2g1b-TreatmentRelatedChanges
in Lipid Abundance
Relative abundances of phosphatidylethanolamine
(PE) and other lipids extracted from PLA2g1B-
treated (10 ng/mL) and control-treated (0 ng/mL)
larvae.
(A) Identified PEs. Features were regarded as
‘‘identified’’ by comparison of their precursor ion and
MS/MS fragments with the LipidBlast library, as
outlined in Figure S1. The arrangement of fatty acid
moieties on the glycerol backbone (i.e., whether in
the sn-1 or sn-2 position) and the position of double
bonds could not be inferred. PE 38:3 and PE 38:4
were detected as a mixture of different fatty acid
moieties.
(B) Putatively identified (annotated) PEs. The fea-
tures could be ‘‘annotated’’ as PEs by comparison of
peak retention time and inter-cluster mass shifts of
28 Da (CH2CH2) and intra-cluster mass shifts of 2 Da
(indicative of difference in double bond number
[fatty acid saturation]) with other, identified PEs.
MS/MS could not be performed due to low abun-
dance. Data are shown as normalized intensities
expressed in arbitrary units. Data are represented as
mean ± SEM, n = 3. * = p < 0.05. TIC: Total ion
current. See also Figure S7.H.p. killing, expulsion, and clearance were completely rescued in
Pla2g1b/ mice when L3 larvae were directly treated with
PLA2g1B (Figure 5E), suggesting that killing and expulsion of
H.p. requires both PLA2g1B-mediated effects on L3 larvae and
immune-mediated expulsion mechanisms.
The requirement for a combined functional immune compart-
ment alongside direct PLA2g1B-mediated action was confirmed
by infecting Rag/cg/ mice with PLA2g1B-treated larvae.
Upon 1 infection, Rag/cg/ mice fail to expel PLA2g1B-
treated larvae, unlike WT mice (Figure 5F) These data highlight
the clear requirement of a competent immune compartment for
parasite expulsion. This observation was reinforced when
Rag/cg/ mice that were infected, drug cured, and chal-
lenged with PLA2g1B-treated L3 larvae failed to expel H.p., un-
like WT mice (Figure 5G). It is important to note that, under these
2 challenge conditions in Rag/cg/ mice, we cannot distin-
guish the requirement of Rag/cg/-driven Pla2g1b expres-
sion (required for parasite killing) from Rag/cg/-dependent
immune responses (required for expulsion).490 Cell Host & Microbe 22, 484–493, October 11, 2017Nevertheless, these data demonstrate
that PLA2g1B has direct anthelminthic
properties distinct from type 2 immune re-
sponses and that PLA2g1B is essential for
intestinal helminth clearance during 2
H.p. infection. Furthermore, these data
add to other discovered anti-microbial
properties of sPLA2 enzymes (Balestrieri
et al., 2009; Degousee et al., 2002; Koduri
et al., 2002; Maizels and Hewitson, 2016;
Weinrauch et al., 1998) and to the site-spe-
cific arsenal of anti-microbial responses
in the small intestine (Gallo and Hoop-
er, 2012).Finally, to identify the direct effects of PLA2g1B on H.p. L3
larvae, we treated larvae for 24 hr with PLA2g1B or control buffer
and subjected the treated larvae to scanning electron micro-
scopy (SEM) and lipid composition analysis using liquid chroma-
tography-mass spectrometry (LC-MS). Although SEM did not
reveal any structural changes or alterations in membrane integ-
rity (Figure S5E), LC-MS analysis identified a significantly lower
phospholipid abundance in the PLA2g1B-treated larvae when
compared to untreated controls (Figure S6A). Of the 1,165 apolar
features detected, only 112 were significantly different following
PLA2g1B treatment; 6 were identified as phosphatidylethanol-
amines (PEs) (by comparing their precursor ion and MS/MS
fragments with the LipidBlast library) (Figures 6A and S6A–
S6E), with each being of lower abundance in the treated
larvae. We also identified a similar trend in a number of putatively
identified PEs (as determined by comparison of peak retention
time with other identified PEs, together with intercluster mass
shifts of 28 Da (CH2CH2) and intracluster mass shifts of 2 Da,
indicative of differences in double-bond number, i.e., saturation)
(Figure 6B). The remaining, significantly different apolar features
were seen to be both increased and decreased following
PLA2g1B treatment; however, these features were unable to
be identified (examples shown in Figure S6F). PEs are highly
abundant phospholipids found in membranes of bacteria, yeast,
and mammals and are required for an array of cellular functions
includingmembrane fusion, cytokinesis, cell division, membrane
curvature, and as a substrate for subsequent products (Wellner
et al., 2013). The relative reduction in PEs in PLA2g1B-treated
H.p. L3 larvae provides one explanation for many putative down-
stream impacts on larval integrity, health, and infectivity. For
example, studies in yeast and Caenorhabditis elegans identified
that low levels of PE can cause ER stress and disrupt vesicle traf-
ficking (Wang et al., 2014). Whether similar effects are observed
in PLA2g1B-treated H.p. are currently unclear. Another possible
explanation is that reducing larval phospholipids may allow for
greater immune cell recognition and larval trapping in the tissue
(Anthony et al., 2006; Esser-von Bieren et al., 2015), although this
has not been tested here.
Taken together, our data uncouple type 2 immune-mediated
anti-helminth expulsion mechanisms from the production of
host enzymes that mediate direct anti-helminth activity, which
are regulated by the microbiota and require competent innate
and adaptive immunity. Specifically, we highlight a previously
overlooked role for epithelial-cell-derived PLA2g1B as an
essential endogenous anthelmintic that has direct effects on
invading larvae, possibly by reducing phospholipid levels. Iden-
tifying mechanisms that regulate site-specific expression of
Pla2g1b and the functional role of phospholipids in helminths
may provide avenues toward greater protection from helminth
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Strains
All mice used in this studyweremaintained under specific pathogen-free conditions at theMill Hill Laboratory, The Francis Crick Insti-
tute (London, UK). C57BL/6, Pla2g1b/ (Richmond et al., 2001), 4get (Mohrs et al., 2001), Rag–/–cg–/– and Rag2–/– mice were bred
and maintained at The Francis Crick Institute. Pla2g1b/Il4gfp mice were generated by crossing Pla2g1b/ and 4get mice at The
Francis Crick Institute. All mice used were male and between 6-12 weeks old at the start of the experiment and were not involved in
any previous procedures. Animal experiments were performed according to institutional guidelines and following UK Home Office
regulations (project license 70/8809) and were approved by The Francis Crick Institute Ethical Review Panel.
Organoid Culture
Mouse organoids were established andmaintained at 37C as three-dimensional spheroid culture in Matrigel (R&D system) from iso-
lated crypts collected from the duodenum of male C57BL/6 mice. The basic culture medium (ENR) contained advanced DMEM/F12
supplemented with penicillin/streptomycin, 10mMHEPES, 2mMGlutamax, B27 (all from Life Technologies) and 1cmMN-acetylcys-
teine (Sigma) supplemented with murine recombinant EGF (life technologies), R-spondin1-CM (Trevigen) (10% final volume) and
Noggin-CM (kindly provided by Dr. Hans Clevers, Hubrecht Institute, Utrecht, the Netherlands) (20% v/v). Wnt3a-CM was used at
50% (v/v) for 7 days at the beginning of the culture, then withdrawn. Organoids were stimulated with 20 ng/mL IL-4 (R&D) and
20ng/mL IL-13 (R&D) for 48 hr. RNA was extracted and qRT-PCR performed as described below.
Bone Marrow-derived Macrophage (BMDM) Culture and Stimulation
Bone marrow was isolated from the femur and tibia of mice and the red blood cells were lysed with ACK lysis buffer (GIBCO). The
remaining cells were then cultured in DMEM (GIBCO) (with 20% L929 cell media (in-house preparation), 10% FCS (Invitrogen),
1%L-Glutamine (GIBCO), 100 U/mL Penicillin and 100 mg/mL Streptomycin (GIBCO), 10mMHEPES (Lonza) and 0.05mM2-mercap-
toethanol (GIBCO)) in 10mls at a density of 5x105 cells/ml at 37C. After 7 days of culture non-adhesive cells were removed before
removing adherent BMDMs using 2.5mMedta (Invitrogen) in PBS (GIBCO) with 5%FCS (Invitrogen). Adherent BMDMSwerewashed
and resuspended in DMEM (with 1% FCS (Invitrogen), 1% L-Glutamine (GIBCO), 100 U/mL Penicillin and 100 mg/mL Streptomycin
(GIBCO), 10 mMHEPES (Lonza) and 0.05mM 2-mercaptoethanol (GIBCO)). Adherent BMDMs were then plated at a density of 2x106
cells/ml for 24 hr. The adherent BMDMswere then stimulated for 24 hr with either 20ng/ml IL-4 (R&D) and 20ng/ml IL-13 (R&D) before
RNA extraction.
METHOD DETAILS
Parasite Infections and PLA2g1B Treatment
Heligmosomoides polygyrus bakeri
Mice were infected with 200 L3 infective H. polygyrus larvae (p.o.) on day 0 (1 infection). Mice were drug cured (Rx) with the anthel-
minthic drug Pyrantel Embonate (2.5 mg/dose, Pfizer) (p.o.) on days 14 and 15. Mice were secondary (2) challenge infected on day
35 or day 56 with 200 L3 infectiveH. polygyrus larvae (p.o.).H. polygyruswormswere counted in the wall of the intestine at day 5 post
infection and luminal worms were counted 14 days-post 1 or 2 infection.
Nippostrongylus brasiliensis
Mice were infected with 350 L3 infective N. brasiliensis larvae (s.c.) on day 0. Luminal N. brasiliensis worms were counted on day 8.Cell Host & Microbe 22, 484–493.e1–e5, October 11, 2017 e2
Trichuris muris
Mice were infected with 200 embryonated T. muris eggs (p.o.) on day 0. Luminal T. muris worms were counted on day 35. For
PLA2g1B treatment, infective L3 H. polygyrus larvae were exsheathed as previously described (Sommerville and Bailey, 1973).
Briefly, 0.85%w/v NaCl (in distilled water) was bubbled with 40%CO2 in Nitrogen for 5 min, the tube was then sealed and incubated
in a 37Cwaterbath for a further 5 min. The pH was adjusted to pH2 using HCl and 5 mL was added to 30000-50000 L3 larvae before
bubbling with 40% CO2 in Nitrogen for 30 s. The tube was then sealed and incubated in a 37
C waterbath for a further 30 min. Ex-
sheathed L3 larvae were washed and counted before treatment with PLA2g1B. 8000 exsheathed L3H. polygyrus larvae were treated
with recombinantmouse PLA2g1B (Elabscience), recombinant mouse PLA2g1B plusmanoalide (200 ng/mL final concentration, Santa
Cruz Biotechnology) or heat inactivated recombinant mouse PLA2g1B in 1mL EnzChek
 PLA2 reaction buffer (Invitrogen) at room
temperature for 24 hr. Recombinant mouse PLA2g1B was heat inactivated by heating at 100
C for 4 hr. Following treatment, larvae
were washed withMilliQ water prior to use in ATP assay (detailed below) or infection. Adult L5H. polygyruswormswere isolated from
C57BL/6 following primary infection between days 14 and 28 using a modified Baermann apparatus. Adult L5 H. polygyrus worms
were treated with recombinant mouse PLA2g1B (Creative Biomart) or heat inactivated recombinant mouse PLA2g1B in EnzChek

PLA2 reaction buffer (Invitrogen) at room temperature for 24 hr.
ATP Assay
The ATP of infective L3 H. polygyrus larvae, L4 H. polygyrus larvae (removed from intestinal wall at day 7 post infection) and adult L5
H. polygyrus worms was measured using the CellTiter-Glo Luminescent Cell Viability Assay (Promega). Briefly, H. polygyrus adult
worms, two L4 larvae or 100 L3 larvae were homogenized using a motorised pestle in 110 mL of PBS and 110 mL of CellTiter-Glo
Reagent. The homogenate was incubated for 10 min at room temperature before centrifugation at 1000 g for 3 min. 200 mL of the
supernatant was transferred to a 96 well opaque-walled plate and incubated for 10 min at room temperature before recording lumi-
nescence. An ATP standard curve was generated by using recombinant ATP (Promega) as detailed in the CellTiter-Glo Luminescent
Cell Viability Assay instructions.
Antibiotic Treatment
The antibiotics Gentamicin sulfate salt (1 mg/mL, Sigma), Metronidazole (1 mg/mL, Sigma), Cefloxin sodium salt (1 mg/mL, Santa
Cruz Biotechnology), Vancomycin hydrochloride (1 mg/mL, Sigma) were administered in the drinking water. Treatment was started
7 days prior to 1 H. polygyrus infection and maintained throughout the duration of the experiment.
Antibody Treatment
Anti-IL-4 antibody (0.5 mg/dose, BioXcell) was administered i.p. on days 13, 15, 17, 19 and 21 after 1 H. polygyrus infection. Mice
were drug cured (Rx) with the anthelminthic drug Pyrantel Embonate (2.5 mg/dose, Pfizer) (p.o.) on days 14 and 15.
Histology, In Situ Hybridization
Small intestinal tissuewas removed and fixed in 4% formaldehyde for 24 hr thenwashed in 70%ethanol. The tissueswere embedded
in paraffin, and sectioned. Sections were stained with hematoxylin and eosin stain or Alcian blue/ periodic acid-Schiff stain. Pla2g1b
Staining: Pla2g1b RNAscope probes were designed by Advanced Cell Diagnostics and in situ hybridization was performed with
RNAscope 2.5 Reagent Kit Brown (Advanced Cell Diagnostics), following the manufacturer’s instructions. The final Pla2g1b signal
was detected chromogenically using DAB and the sections were counterstained with Haematoxylin Stained. Stained slides were
scanned with a VS120-SL slide scanner (Olympus, Tokyo, Japan) and images were captured with the OlyVIA image viewer
(Olympus).
RNA Sequencing and Analysis
RNA was extracted using the QIAGENmiRNeasy Mini Kit, following the manufacturer’s instructions. RNA integrity was confirmed
using Agilent’s 2100 Bioanalyser. Total RNA libraries were created using the Encore Complete RNA-Seq Library Systems kit
(NuGEN), following manufacturer’s instructions. Total RNA libraries were sequenced using the Illumina HiSeq 2500. The raw Illu-
mina reads were analyzed as follows. First, the data quality was analyzed using FastQC (www.bioinformatics.babraham.ac.uk/
projects/fastqc). Then the low quality bases were trimmed using Trimmomatic. The read pairs which passed the trimming quality fil-
ters were then aligned to mm10 (Ensembl version 75) using Tophat2. Counts were determined using htseq_count. Normalization and
statistical analysis was performed using edgeR. Differential gene analysis was calculated from naive control group. Statistically sig-
nificant genes with FDR < 0.05 are reported. Ingenuity Pathway Analysis (IPA): RNA sequencing datasets were uploaded to IPA
where fold change filters and pathway analysis algorithms were applied. Ratio of ratios plots were generated from the ratio of expres-
sion of genes from H.p. 2 to H.p. 1 (relative to naive, 2-fold filter, p < 0.05) (y axis) against the fold-change of each gene in both
compared to naive (2-fold filter, p < 0.05) (x axis).
Quantitative Real-time Polymerase Chain Reaction
RNA was extracted and purified from tissue or cells as described above. Reverse transcription was performed with 0.1-1 mg RNA
using QIAGENQuantitect RT Kit following manufacturer’s instructions to create cDNA. Generated cDNA was used for quantitative
real-time PCR analysis using Power SYBR Green PCR Master Mix (Applied Biosystems) and quantified on the 7900HT (Appliede3 Cell Host & Microbe 22, 484–493.e1–e5, October 11, 2017
Biosystems). Where appropriate, relative gene expression was determined via normalization to the housekeeping gene Hprt and the
relevant control group (see Figure legends and Table S4).
PLA2 Activity Assay
PLA2 activity was determined using EnzChek
 Phospholipase A2 Assay Kit (Invitrogen), following manufactures instructions. Briefly,
approximately 1cm of duodenal tissue was removed and homogenized in 300 mL of cOmplete protease inhibitor (Roche) before
centrifugation. 25 mL of the supernatant was transferred to a 96 XXX well plate with 25 mL of the substrate-liposome mix then incu-
bated at room temperature in the dark for 10min. Fluorescence emissionwasmeasured at 515nmand reported after blank reduction.
Cell Isolation
The spleen, mLNs and thymus were made into single-cell suspensions by gently mashing through a 40 micron filter (Thermo-Scien-
tific, Loughborough, UK), and the red blood cells were lysed from the spleen single cell suspension with ACK lysis buffer (GIBCO).
Single cell suspensions were used for ex vivo restimulations and flow cytometry analysis. For the isolation of small intestinal epithelial
cells: adipose tissue was removed from the small intestine dissected longitudinally to remove faecal contents, and cut into 2cm seg-
ments. The epithelial layer was then dissociated by in incubating the intestine segments in PBS containing 10%FBS, 15cmmHEPES,
5cmm EDTA (Life Technologies, Paisley, UK), and 1cmm dithiothreitol (Sigma, Gillingham, UK) for 30cminutes at 37cC. The remain-
ing intestinal tissue was removed using a wide mesh sieve and epithelial layer was retained. Cells were layered onto 20% isotonic
Percoll (GE Healthcare, Little Chalfont, UK) to remove debris. Cells were then resuspended in cIMDM (complete Iscove’s Modified
Dulbecco’s Medium (cIMDM) containing 1% fetal bovine serum (FBS), 1mM EDTA, 100U/ml Penicillin (GIBCO) and 100 mg/ml Strep-
tomycin (GIBCO), 8mM L-glutamine (GIBCO) and 0.05mM 2-mercaptoethanol (GIBCO)) and prepared for cell sorting.
Flow Cytometry and Cell Sorting
Cell sorting was performed using a MoFlo XDP cell sorter (Beckman Coulter). Cell suspensions were stained for 25 min with anti-
bodies in PBS with 1% FCS. To prepare for sorting, stained cells were diluted in phenol-red free IMDM (GIBCO) (with 1% FCS,
2mMEDTA (Invitrogen), 100 U/mL Penicillin and 100 mg/mL Streptomycin (GIBCO), 8 mM L-glutamine (GIBCO), and 0.05mM 2-mer-
captoethanol (GIBCO)). For flow cytometry analysis, cells were analyzed using a BD LSRFortessa X-20 (BD Biosciences) or BD LSRII
(BD Biosciences) and data were analyzed using FlowJo software (Version 10, Treestar Inc). Cells were sometimes fixed in 2%–4%
paraformaldehyde for FACS analysis. For cell sorting, viability of the cells was determined using Propidium Iodide (Sigma); for
analysis, viability of the cells was determined using the LIVE/DEAD Fixable Blue kit (Life Technologies). Antibodies used include:
CD3 (145-2C11; APC, (BioLegend)), CD4 (RM4-5; BV605, efluor450 (eBioscience), APC (BioLegend)), CD8 (53-6.7; PE-Cy7, APC
(BioLegend)), CD11c (N418; APC (BioLegend)), CD11b (M1/70; APC (BioLegend)), CD19 (1D3; efluor450 (eBioscience)), CD19
(6D5; APC (BioLegend)), CD25 (PC61; APC-Cy7 (BioLegend), APC (eBioscience)), CD44 (IM7; Percpcy5.5 (eBioscience)), CD45
(30-F11; FITC (Bioscience)), CD49b (DX5; APC (BioLegend)), CD62L (MEL-14; APC (eBioscience)), CD69 (H1.2F3; PE (BioLegend)),
EpCam (G8.8; APC (eBioscience), Foxp3 (FJK-16S; PE (eBioscience)), Gr1 (RB68C5; APC (BioLegend)), IFNg (XMG1.2; PE (BD
Bioscience)), IL4 (PE, 11B11, eBioscience)), IL17a (17B7; PE-Cy7 (eBioscience)), KLRG1 (2F1; PerCpefluor710 (eBioscience)),
NK1.1 (PK136; APC (BioLegend)), Sca1 (E13-161.7; PB (eBioscience)), TCRgd (GL3; APC (BioLegend)), TCRab (H57-597; APC
(eBioscience)), TCRb (H57-597; Percpcy5.5 (BioLegend)), Ter119 (TER-119; APC (BioLegend)), Thy1.2 (53-2.1; PE-Cy7 (BioLegend)).
All staining was performed in the presence of FcR Blocking Reagent (Miltenyi Biotec). Intracellular cytokine staining (ICS) was per-
formed following 6 hr of re-stimulation with 50ng/mL phorbol 12-myristate 13-acetate (PMA, Promega) and 1 mg/mL ionomycin
(Sigma) and BD Golgi Stop and BD Golgi Plug (diluted 1:1000, BD Biosciences). Following surface stain, cells were incubated
with eBioscience Fixation/Permeabilization buffer for 25 min followed by 25 min in Permeabilization buffer (eBioscience), and incu-
bation with antibodies in Permeabilization buffer for a further 30 min. ILCs were analyzed using the following strategy: Live, lympho-
cytes, CD45+, Lineage– (CD3, CD4, CD8, CD19, CD11c, CD11b, NK1.1, TCRb, TCRgd, Gr-1, CD49b, Ter119), Thy1.2+, KLRG1+,
and Sca1+.
Tregs were analyzed using the following gating strategy: Live, lymphocytes, CD4+, TCRb+, CD25+ and Foxp3+. Epithelial cells were
sorted using the following gating strategy: Live, CD45– and EpCam+.
Ex Vivo Stimulations
mLNs were harvested and processed as above. Cells were plated at 2x105 cells per 200ml with 10mg/ml of H. polygyrus antigen
extract (HEX). Supernatant was harvested after 4 days. Cytokines were detected in the supernatant using ELISAs.
ELISAs
IFNg, IL-5 and IL-13 were measured using DuoSet ELISA kits, according to the manufacturer’s instructions (R&D). Cysteinyl leuko-
trienes and prostaglandin E2 were measured in small intestinal homogenate (see above) using ELISA kits, according to manufac-
turer’s instructions (Enzo), and normalized to total protein content. Total IgE ELISA was performed by coating with Purified
Rat Anti-Mouse IgE (R35-72, BD PharMingen) at 2 mg/mL overnight, followed by overnight incubation with serum and
standard (Purified Mouse IgE,k isotype Standard, BD PharMingen), and detection with Biotin Rat Anti-Mouse IgE at 1 mg/mL
(R35-118, BD PharMingen), Streptavidin HRP at 1:000 (BD PharMingen) and ABTS One Component HRP Microwell Substrate
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overnight incubation with serially diluted serum and detection with Biotin Rat Anti-Mouse IgG1 (Invitrogen) and streptavidin and
ABTS, as above.
Scanning Electron Microscopy (SEM)
H. polygyrus larvae were dehydrated stepwise in ethanol (23 5min in 70, 90 and 100% ethanol) before transferring to 100% acetone
(23 5 min). Larvae were critical point dried from 100%Ethanol in a CPD300 critical point drier (Leica Microsystems UK), mounted on
a carbon sticky pad on a stub, sputter-coated with 5 nm of platinum, and imaged in a Phenom ProX benchtop scanning electron
microscope (Phenom-World) with a secondary electron detector.
Serum Chemistry
Whole blood was collected from mice and the serum separated after clotting. The serum was sent to the MRC Harwell Institute (UK)
for metabolite analysis. Lysophosphatidylcholine (LPC) was measured using the AZWELL LPC Assay Kit according to the manufac-
turer’s instructions (Cosmo Bio).
Lipid Extraction and Analysis
Lipids were extracted fromH. polygyrus L3 larvae using amethod adapted from a previous publication (Meyer et al., 1966). Following
PLA2g1B treatment8000H. polygyrus larvae werewashed three timeswithMilliQ water, resuspended in 2mLmethanol and heated
in a sealed tube under nitrogen at 55C for 20 min. After cooling, 4 mL chloroform was added and the sample was agitated with a
magnetic stirrer for 3 hr. The organic phase was removed and the residue ground (using a glass homogenizer) and extracted with
2 mL chloroform/methanol (2:1, v/v) for 2 hr.
For LC-MS, lipids were dried under nitrogen and redissolved in 100 mL of methanol/chloroform (1:1 v/v) and diluted 1:2 with solvent
A (hexane:isopropanol, 70:30 [v: v], 0.02% [m/v] formic acid, 0.01% [m/v] ammonium hydroxide), centrifuged at 1,500 rpm for 5min to
remove trace non-lipidic materials prior to transfer to a glass autosampler vial (Agilent). 10 mL was injected onto a BETASIL diol
column (5 um x 150 mm x 2.1 mm, with BETASIL diol guard column (10 mm x 2.1 mm), held at 20C) in an Ultimate 3000 HPLC
system coupled to a Thermo Exactive Plus Orbitrap MSfor full scan or Q Exactive Orbitrap MS for MS/MS scan. Lipids were eluted
at 0.15 ml/min with a binary gradient from 0% to 100% solvent B (isopropanol:methanol, 70:30 [v/v], 0.02% [m/v] formic acid, 0.01%
[m/v] ammonium hydroxide): 0–10min, 0%B; 17–22min, 50%B; 30–35min, 100%B; 40–44min, 0%B, followed by additional 6 min
0% B post-run. MS data were acquired in both polarities using a full scan method. The positive and negative HESI-II spray voltages
were 4.5 and 3.5 kV, respectively; the heated capillary temperature was 250C; the sheath gas pressure was 30 psi; the auxiliary gas
setting was 20 psi; and the heated vaporizer temperature was 150C. Both the sheath gas and the auxiliary gas were nitrogen. The
parameters of the full mass scan were as follows: a resolution of 70,000, an auto gain control target under 33 106, a maximum isola-
tion time of 200 ms, and an m/z range 200–3000. To confirm the identification of significant features, samples were re-ran in parallel
reaction monitoring (PRM_ mode, parameters as follows: a resolution of 17,500, an auto gain control target under 2 3 105, a
maximum isolation time of 100 ms, an isolation window of m/z 0.4 and normalized collision energy were optimized for each feature
individually. Data were acquired using Xcalibur 3.0.63 (Thermo Fisher Scientific) and Progenesis (Nonlinear Dynamics) was used for
data alignment and peak detection. Data were normalized against the total ion abundance.
Annotations were assigned to accurate masses with a maximum error of 5 ppm using Metlin, LipidMaps, Kegg and HMDB which
were searched simultaneously using the CEU Mass Mediator engine (http://ceumass.eps.uspceu.es/mediator/).
Experimental Design
All experiments contained at least three biological replicates and are representative of at least two independent experiments (see
figure legends for exact values). No strategy was employed for randomization, sample size estimation or data inclusion/exclusion
criteria. The studies performed were also not blinded at any stage.
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical analysis for biological data was performed using GraphPad Prism (v6.02). Data was analyzed, where appropriate, with
either an unpaired two-tailed t test, One-way ANOVA (Dunnett’s multiple comparison analysis), Two-way ANOVA (Sidak’s multiple
comparison analysis) or Mann-Whitney test. n represents the number of biological replicates. Please see figure legends for statistical
tests used and exact value of n. No methods were used to confirm whether the data met assumptions of the statistical approach
used. Values are reported as the means ± SEM. * = p < 0.05, ** = p < 0.01, *** = p < 0.001 and **** = p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
The raw and analyzed RNA sequencing data files have been deposited in the NCBI Gene Expression Omnibus database under ID
code GEO: GSE102789. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102789
LC-MSmetabolomics data have been deposited in the EMBL-EBIMetaboLights database under ID codeMTBLS523 and PubMed
PMID: 23109552. http://www.ebi.ac.uk/metabolights/MTBLS523e5 Cell Host & Microbe 22, 484–493.e1–e5, October 11, 2017
